AtriCure, Inc.
ATRC
$37.86
$0.1950.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.28% | 15.79% | 16.55% | 17.56% | 17.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.28% | 15.79% | 16.55% | 17.56% | 17.57% |
| Cost of Revenue | 16.89% | 18.15% | 19.12% | 18.72% | 17.34% |
| Gross Profit | 16.07% | 15.02% | 15.70% | 17.17% | 17.65% |
| SG&A Expenses | 8.95% | 11.00% | 14.91% | 18.85% | 16.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.89% | 15.28% | 18.53% | 19.45% | 18.91% |
| Operating Income | 2.20% | -8.75% | -47.68% | -51.39% | -38.28% |
| Income Before Tax | 10.17% | -1.54% | -46.33% | -54.36% | -41.76% |
| Income Tax Expenses | 27.10% | 55.17% | 73.27% | 233.63% | 153.25% |
| Earnings from Continuing Operations | 9.38% | -2.54% | -46.85% | -56.81% | -43.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.38% | -2.54% | -46.85% | -56.81% | -43.11% |
| EBIT | 2.20% | -8.75% | -47.68% | -51.39% | -38.28% |
| EBITDA | 19.96% | 1.40% | -73.26% | -78.38% | -37.63% |
| EPS Basic | 10.62% | -1.21% | -44.87% | -54.97% | -41.15% |
| Normalized Basic EPS | 8.23% | -2.86% | -37.93% | -44.64% | -33.01% |
| EPS Diluted | 10.62% | -1.21% | -44.87% | -54.97% | -40.64% |
| Normalized Diluted EPS | 8.23% | -2.86% | -37.93% | -44.64% | -33.01% |
| Average Basic Shares Outstanding | 1.53% | 1.45% | 1.42% | 1.34% | 1.29% |
| Average Diluted Shares Outstanding | 1.53% | 1.45% | 1.42% | 1.34% | 1.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |